Clinical Trial Update: IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

View source ↗

Summary

The IMPAACT P1085 trial evaluating a human papillomavirus type-specific antibody has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV type-specific antibody (Human papillomavirus type-specific antibody)

Snippet

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Conditions: Papilloma Virus, Human | Status: COMPLETED